T2 Biosystems, Inc. 4
4 · T2 Biosystems, Inc. · Filed Dec 9, 2015
Insider Transaction Report
Form 4
AISLING CAPITAL III LP
10% Owner
Transactions
- Purchase
Common Stock
2015-12-09$9.75/sh+307,692$2,999,997→ 2,830,992 total(indirect: See footnote)
Footnotes (1)
- [F1]The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP. Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling.